[{"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-001", "question": "A 34-year-old female with a history of oral contraceptive use presents with right upper quadrant pain. MRI of the liver reveals a 6 cm solitary lesion in segment V. The lesion is hyperintense on T2-weighted images, shows strong arterial enhancement, and retains contrast on the hepatobiliary phase of Eovist (gadoxetate) MRI. Biopsy shows hepatocytes with glutamine synthetase diffuse strong positivity. What is the most appropriate management?", "options": ["Discontinue oral contraceptives and surveillance imaging in 6 months", "Surgical resection", "Radiofrequency ablation", "Liver transplantation evaluation", "Reassurance and discharge"], "answer": "B", "answer_index": 1, "explanation": "The imaging and staining pattern (diffuse glutamine synthetase positivity) are diagnostic of a beta-catenin activated hepatocellular adenoma. Unlike HNF1A-inactivated or inflammatory adenomas, beta-catenin activated adenomas have a very high risk of malignant transformation to hepatocellular carcinoma (HCC) and do not regress significantly with OCP cessation. Resection is mandated regardless of size or symptoms.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "The patient is a 34-year-old female with a history of oral contraceptive use presenting with a 6 cm liver lesion. The differential diagnosis for a hypervascular liver lesion in a young woman taking oral contraceptives primarily includes hepatic adenoma (HCA) and focal nodular hyperplasia (FNH).\n\nMRI features show the lesion is hyperintense on T2, has arterial enhancement, and retains contrast on the hepatobiliary phase of Eovist MRI.\n- FNH typically retains contrast on the hepatobiliary phase (iso- or hyperintense) due to the presence of functional hepatocytes and biliary canaliculi.\n- Classic Hepatic Adenomas (HNF1A-inactivated or Inflammatory) typically appear hypointense on the hepatobiliary phase because they lack bile ducts/transport mechanisms.\n- However, Beta-catenin activated Hepatic Adenomas (b-HCA) can show iso- or hyperintensity (retention of contrast) on the hepatobiliary phase due to overexpression of OATP1B1/3 transporters.\n\nThe biopsy finding is the critical differentiator:\n- FNH is characterized by \"map-like\" glutamine synthetase (GS) staining.\n- Beta-catenin activated HCA (and Hepatocellular Carcinoma) is characterized by diffuse strong glutamine synthetase staining (and often nuclear beta-catenin accumulation).\n\nThe presence of \"glutamine synthetase diffuse strong positivity\" confirms the diagnosis of a Beta-catenin activated Hepatic Adenoma (b-HCA), distinguishing it from FNH despite the imaging similarities. Beta-catenin activated adenomas are associated with a significantly increased risk of malignant transformation into Hepatocellular Carcinoma (HCC).\n\nManagement Guidelines for Hepatic Adenoma:\n1.  Resection is recommended for all adenomas > 5 cm (due to risk of hemorrhage).\n2.  Resection is recommended for all adenomas with beta-catenin activation (due to risk of malignancy).\n3.  Resection is recommended for symptomatic adenomas.\n\nThis patient meets all three criteria (6 cm, beta-catenin positive, symptomatic). Therefore, surgical resection is the appropriate management. If the lesion were FNH (map-like GS), reassurance would be appropriate, but the pathology rules this out.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-002", "question": "A 48-year-old male who works as a tool grinder presents with chronic dry cough and dyspnea. Bronchoalveolar lavage (BAL) reveals multinucleated giant cells that appear to be engulfing other cells ('cannibalistic' giant cells). Which of the following exposures is most likely responsible for this finding?", "options": ["Silica", "Asbestos", "Cobalt", "Beryllium", "Coal dust"], "answer": "C", "answer_index": 2, "explanation": "The presence of 'cannibalistic' multinucleated giant cells in BAL or biopsy is pathognomonic for Hard Metal Lung Disease (Giant Cell Interstitial Pneumonia). This is caused by exposure to Cobalt, often in the form of tungsten carbide alloy used in tool grinding, diamond polishing, or saw sharpening. Beryllium causes granulomas similar to sarcoidosis, not GIP.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "C", "model_outputs": "Based on the patient's occupation and the specific findings in the bronchoalveolar lavage (BAL), here is the step-by-step reasoning:\n\n1.  Occupation (Tool Grinder): Tool grinders are typically exposed to \"hard metals,\" which are alloys often composed of tungsten carbide with cobalt used as a binding agent.\n2.  Pathology (Cannibalistic Giant Cells): The finding of multinucleated giant cells engulfing other cells (phenomenon known as emperipolesis or \"cannibalism\") is characteristic of Giant Cell Interstitial Pneumonia (GIP).\n3.  Diagnosis: GIP is the pathognomonic histological pattern associated with Hard Metal Lung Disease.\n4.  Causative Agent: While the alloy contains tungsten carbide, the specific component responsible for the hypersensitivity reaction and the resulting interstitial lung disease is Cobalt.\n\nAnalysis of other options:\n*   Silica: Causes silicosis, characterized by silicotic nodules and macrophages containing birefringent particles, not cannibalistic giant cells.\n*   Asbestos: Causes asbestosis, characterized by ferruginous bodies (asbestos bodies) and interstitial fibrosis.\n*   Beryllium: Causes chronic beryllium disease, which manifests as non-caseating granulomas similar to sarcoidosis.\n*   Coal dust: Causes coal workers' pneumoconiosis, characterized by coal macules and black pigment-laden macrophages.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-003", "question": "A 29-year-old male who has sex with men presents with severe proctitis, tenesmus, and rectal bleeding. Rectal swab NAAT is positive for *Chlamydia trachomatis*. He was treated with Doxycycline 100 mg BID for 7 days with no improvement. His partner recently returned from Europe. Which of the following is the most appropriate management?", "options": ["Repeat Doxycycline 100 mg BID for 7 days", "Azithromycin 1 g single dose", "Ceftriaxone 500 mg IM single dose", "Extend Doxycycline 100 mg BID to complete a 21-day course", "Moxifloxacin 400 mg daily for 14 days"], "answer": "D", "answer_index": 3, "explanation": "Severe proctitis in MSM with a positive Chlamydia test should raise suspicion for Lymphogranuloma Venereum (LGV), caused by L1, L2, or L3 serovars. LGV requires a prolonged course of doxycycline (21 days) compared to non-LGV chlamydia (7 days). Standard treatment failure and severe symptoms (bleeding/tenesmus) strongly support a diagnosis of LGV.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "topics_mapped", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed124.jsonl", "pred": "D", "model_outputs": "This patient presents with severe proctitis, tenesmus, and rectal bleeding, which are classic symptoms of Lymphogranuloma Venereum (LGV), particularly in men who have sex with men (MSM). The recent travel of his partner from Europe is also an epidemiological clue, as LGV outbreaks have been significant in the MSM community in Europe.\n\nWhile standard rectal chlamydia (serovars D-K) is treated with Doxycycline for 7 days, LGV (serovars L1, L2, L3) is an invasive lymphatic infection that requires a longer course of treatment. The recommended treatment for LGV is Doxycycline 100 mg orally twice daily for 21 days.\n\nThe standard Chlamydia NAAT is positive, but it does not differentiate between serovars. However, given the severity of symptoms (severe proctitis vs. mild or asymptomatic presentation of non-LGV strains) and the failure of the 7-day course (which would usually suffice for non-LGV strains), the clinical diagnosis is presumptive LGV.\n\nTherefore, the appropriate management is to extend the duration of Doxycycline therapy to complete the recommended 21-day course for LGV.\n\nOption A is incorrect because another short course is insufficient for LGV.\nOption B is incorrect because a single dose of Azithromycin is not effective for LGV.\nOption C covers Gonorrhea, but the agent identified is Chlamydia, and the clinical picture fits LGV.\nOption E is not a standard treatment for Chlamydia or LGV.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-004", "question": "A neonate with Down syndrome presents with hepatosplenomegaly and a high white blood cell count consisting of blasts. A diagnosis of Transient Myeloproliferative Disorder (TMD) is made. Mutation analysis of the blasts would most likely reveal a mutation in which gene?", "options": ["JAK2", "GATA1", "RUNX1", "ETV6", "BCR-ABL"], "answer": "B", "answer_index": 1, "explanation": "TMD in Down syndrome is uniquely associated with somatic mutations in the GATA1 gene, which encodes a transcription factor required for erythroid and megakaryocytic differentiation. While TMD often resolves spontaneously, these patients are at increased risk for developing Acute Megakaryoblastic Leukemia (AMKL) later in childhood.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-011", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "B", "model_outputs": "The clinical scenario describes a neonate with Down syndrome (Trisomy 21) diagnosed with Transient Myeloproliferative Disorder (TMD), also known as Transient Abnormal Myelopoiesis (TAM).\n\n1.  Context: TMD occurs in approximately 10% of newborns with Down syndrome. It is characterized by the proliferation of megakaryoblasts, often causing hepatosplenomegaly and leukocytosis. While it often resolves spontaneously, it is a pre-leukemic condition that can progress to Acute Megakaryoblastic Leukemia (AMKL).\n2.  Pathogenesis: The development of TMD and subsequent leukemia in Down syndrome is strongly linked to mutations in the GATA1 gene. *GATA1* encodes a transcription factor crucial for the development of erythroid and megakaryocytic lineages.\n3.  Specific Mutation: The mutations found in TMD are acquire, somatic mutations (usually insertions or deletions in exon 2) that introduce a premature stop codon. This leads to the production of a truncated protein isoform known as GATA1s (short), which lacks the N-terminal activation domain but retains DNA-binding capability.\n4.  Association: *GATA1* mutations are detected in nearly all cases of TMD and Down syndrome-associated AMKL. They are not typically found in AMKL occurring in patients without Down syndrome.\n\nAnalysis of other options:\n*   JAK2: Mutations (e.g., V617F) are characteristic of myeloproliferative neoplasms (Polycythemia Vera, Essential Thrombocythemia) in adults.\n*   RUNX1: Translocations (e.g., t(8;21)) are common in de novo AML.\n*   ETV6: Involved in translocations (e.g., t(12;21)) common in childhood B-cell ALL.\n*   BCR-ABL: The hallmark fusion gene of Chronic Myeloid Leukemia (CML) and Ph+ ALL.\n\nTherefore, the blasts in TMD would most likely reveal a mutation in *GATA1*.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-005", "question": "A 22-year-old male is brought to the ED after ingesting a rodenticide. He is alert but complains of extreme weakness. Examination reveals generalized flaccid paralysis. ECG shows premature ventricular complexes. Labs show a serum potassium of 1.8 mEq/L. Which toxin is most likely responsible, and what is the mechanism?", "options": ["Arsenic; uncoupling of oxidative phosphorylation", "Thallium; substitution for potassium in ATPase", "Barium; blockade of potassium efflux channels", "Strychnine; glycine receptor antagonism", "Sodium monofluoroacetate; aconitase inhibition"], "answer": "C", "answer_index": 2, "explanation": "Barium carbonate (found in certain rodenticides and ceramics) causes profound hypokalemia by blocking the inward rectifier potassium channels (Kir), preventing potassium efflux from cells, while the Na-K-ATPase continues to pump potassium in. This results in severe intracellular shift of potassium, leading to paralysis and arrhythmias. Treatment requires aggressive potassium replacement.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "topics_mapped", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed125.jsonl", "pred": "C", "model_outputs": "Here is the step-by-step analysis:\n\n1.  Clinical Presentation: The patient presents with extreme weakness, generalized flaccid paralysis, cardiac arrhythmias (PVCs), and severe hypokalemia (1.8 mEq/L) following rodenticide ingestion.\n\n2.  Evaluate Options:\n    *   A. Arsenic: Acute arsenic poisoning typically causes severe hemorrhagic gastroenteritis, hypotension, and QT prolongation. While electrolyte abnormalities can occur due to fluid loss, profound hypokalemia causing flaccid paralysis is not its primary specific toxidrome.\n    *   B. Thallium: Thallium poisoning is characterized by gastroenteritis followed by painful peripheral neuropathy and alopecia (hair loss) several weeks later. While thallium mimics potassium biologically, severe acute hypokalemia with flaccid paralysis is not the classic presentation.\n    *   C. Barium: Soluble barium salts (found in some rodenticides) are highly toxic. Barium ions block potassium efflux channels (specifically the inward rectifier potassium channels) on cell membranes. However, the Na-K-ATPase pump continues to move potassium into the cells. This results in a massive shift of potassium from the extracellular space into the intracellular space, causing severe hypokalemia. The clinical manifestations of this profound hypokalemia are generalized flaccid muscle paralysis, hyporeflexia, and cardiac arrhythmias (such as PVCs, ventricular tachycardia, and fibrillation). This matches the patient's description perfectly.\n    *   D. Strychnine: Strychnine acts as an antagonist at glycine receptors in the spinal cord. This removes inhibitory control over motor neurons, leading to severe muscle spasticity, rigidity, and opisthotonus (not flaccid paralysis).\n    *   E. Sodium monofluoroacetate: This toxin inhibits aconitase in the Krebs cycle. It leads to metabolic acidosis, citrate accumulation, hypocalcemia, seizures, and arrhythmias, rather than the isolated profound hypokalemic paralysis seen here.\n\n3.  Conclusion: The specific combination of rodenticide ingestion resulting in severe hypokalemia and flaccid paralysis is diagnostic for barium poisoning. The mechanism is the blockade of potassium channels preventing potassium from leaving the cells.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-006", "question": "A 32-year-old G1P0 woman at 35 weeks gestation presents with nausea, vomiting, and jaundice. Labs show AST 300 U/L, ALT 350 U/L, Platelets 80,000/mm3, Glucose 45 mg/dL, and INR 2.5. A diagnosis of Acute Fatty Liver of Pregnancy (AFLP) is made, and the infant is delivered urgently. To prevent sudden death in the neonate, which specific screening test should be prioritized?", "options": ["Option A: Serum ammonia and lactate", "Option B: Plasma acylcarnitine profile", "Option C: Galactose-1-phosphate uridyltransferase", "Option D: Very long-chain fatty acids (VLCFA)", "Option E: Hemoglobin electrophoresis"], "answer": "B", "answer_index": 1, "explanation": "Maternal AFLP is strongly associated with fetal Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Fetal fatty acid oxidation defects cause accumulation of metabolites that cross the placenta and overwhelm the maternal liver. The neonate is at high risk for hypoketotic hypoglycemia and sudden death; an acylcarnitine profile is diagnostic.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "obstetrics", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed126.jsonl", "pred": "B", "model_outputs": "Acute Fatty Liver of Pregnancy (AFLP) is a serious maternal condition characterized by microvesicular fatty infiltration of hepatocytes, typically occurring in the third trimester. It presents with nausea, vomiting, abdominal pain, jaundice, and liver failure (elevated LFTs, coagulopathy, hypoglycemia).\n\nA strong association exists between maternal AFLP and fetal defects in mitochondrial fatty acid oxidation (FAOD), specifically Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. LCHAD is part of the mitochondrial trifunctional protein. When the fetus is homozygous for LCHAD deficiency, it cannot oxidize long-chain fatty acids. The accumulation of toxic fatty acid metabolites (such as long-chain 3-hydroxyacylcarnitines) in the fetus crosses the placenta and overwhelms the maternal liver, causing AFLP in the heterozygous mother.\n\nNeonates with LCHAD deficiency are at high risk for severe non-ketotic hypoglycemia, liver failure, cardiomyopathy, and sudden death (resembling SIDS) if they are subjected to fasting or metabolic stress. Early diagnosis is crucial to initiate dietary management (avoiding fasting, utilizing medium-chain triglycerides).\n\nThe specific screening test used to detect fatty acid oxidation disorders, including LCHAD deficiency, is the plasma acylcarnitine profile. This test utilizes tandem mass spectrometry to identify specific patterns of elevated acylcarnitines (e.g., 3-hydroxy long-chain acylcarnitines in LCHAD deficiency).\n\n*   Option A (Ammonia and lactate) consists of non-specific markers of metabolic derangement but confirms neither the specific diagnosis nor the etiology.\n*   Option C (Galactose-1-phosphate uridyltransferase) screens for Galactosemia, a disorder of carbohydrate metabolism not associated with AFLP.\n*   Option D (Very long-chain fatty acids) screens for peroxisomal disorders (like Zellweger syndrome or Adrenoleukodystrophy), not mitochondrial fatty acid oxidation defects.\n*   Option E (Hemoglobin electrophoresis) screens for hemoglobinopathies.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-007", "question": "A 65-year-old male presents with new-onset intention tremor and gait ataxia. MRI reveals T2 hyperintensities in the middle cerebellar peduncles (MCP sign). He has a grandson with intellectual disability. What is the molecular mechanism of the grandfather's condition?", "options": ["CGG repeat expansion > 200 causing gene methylation and silencing", "CGG repeat expansion between 55 and 200 causing mRNA toxicity", "CAG repeat expansion causing polyglutamine aggregation", "CTG repeat expansion causing RNA foci formation", "Deletion of the FMR1 gene"], "answer": "B", "answer_index": 1, "explanation": "The patient has Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). This occurs in 'premutation' carriers (55-200 CGG repeats) of the FMR1 gene. Unlike Fragile X syndrome (>200 repeats, gene silencing/methylation), FXTAS is caused by a 'toxic gain-of-function' where elevated levels of FMR1 mRNA containing the repeats sequester RNA-binding proteins, leading to neurotoxicity.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-015", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "B", "model_outputs": "This patient presents with symptoms and imaging findings characteristic of Fragile X-associated Tremor/Ataxia Syndrome (FXTAS).\n\n1.  Clinical Picture: The combination of new-onset intention tremor, gait ataxia, and the specific MRI finding of T2 hyperintensities in the middle cerebellar peduncles (known as the MCP sign) is classic for FXTAS in an older male.\n2.  Family History: The grandson with intellectual disability likely has Fragile X Syndrome (FXS). FXS is X-linked. The grandfather passed his X chromosome to his daughter (making her a carrier), who then passed the affected X chromosome to her son.\n3.  Genetics:\n    *   Fragile X Syndrome (Grandson): Caused by a \"full mutation\" of the *FMR1* gene, characterized by >200 CGG repeats. This leads to hypermethylation of the gene promoter and transcriptional silencing (loss of function).\n    *   FXTAS (Grandfather): Occurs in individuals (mostly males) who carry the \"premutation\" of the *FMR1* gene, characterized by 55 to 200 CGG repeats.\n4.  Molecular Mechanism of FXTAS: Unlike the full mutation which leads to silencing, the premutation leads to increased transcription of the *FMR1* gene. However, the translation efficiency is reduced, and the expanded mRNA accumulates in the nucleus. This accumulation results in a toxic gain-of-function mechanism involving mRNA toxicity, where the expanded RNA sequesters specific RNA-binding proteins forms intranuclear inclusions, leading to neuronal cell death.\n\n*   Option A describes the mechanism of Fragile X Syndrome (the grandson's condition), not FXTAS.\n*   Option B correctly identifies the repeat range for the premutation (55-200) and the mechanism (mRNA toxicity) responsible for FXTAS.\n*   Option C describes the mechanism for polyglutamine diseases like Huntington's disease or certain Spinocerebellar Ataxias.\n*   Option D describes the mechanism for Myotonic Dystrophy Type 1.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-008", "question": "A 64-year-old male presents with a 1-year history of progressive gait instability, dysarthria, and dysphagia. His wife reports he has severe insomnia, stridor during sleep, and acts out his dreams. Polysomnography confirms obstructive sleep apnea and complex behaviors during both REM and NREM sleep. MRI brain is unremarkable. Which of the following antibodies is most likely to be positive?", "options": ["Anti-Hu", "Anti-Ma2", "Anti-LGI1", "Anti-IgLON5", "Anti-DPPX"], "answer": "D", "answer_index": 3, "explanation": "Anti-IgLON5 disease is a distinct tauopathy characterized by a unique sleep disorder (parasomnias in both REM and NREM sleep, stridor, OSA) combined with bulbar dysfunction and gait instability. While Anti-Ma2 is associated with brainstem/diencephalic involvement and sleepiness, the specific combination of stridor, NREM parasomnias, and bulbar palsy is pathognomonic for Anti-IgLON5.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed124.jsonl", "pred": "D", "model_outputs": "The clinical presentation describes a syndrome characterized by prominent sleep dysfunction (insomnia, stridor, REM sleep behavior disorder, and parasomnias in both NREM and REM sleep) associated with bulbar symptoms (dysarthria, dysphagia) and gait instability.\n\nThis is the classic phenotype of anti-IgLON5 disease. This disorder is a distinct tauopathy involving the hypothalamus and brainstem, associated with antibodies against IgLON5 (a cell adhesion molecule).\n\n*   Anti-IgLON5 (Option D): The hallmark of this condition is a unique sleep disorder consisting of parasomnias (simple and complex behaviors) occurring in both REM and NREM sleep, along with sleep-disordered breathing (stridor and obstructive sleep apnea). Patients also frequently present with a progressive supranuclear palsy (PSP)-like syndrome (gait instability, falls, vertical gaze palsy) or a bulbar syndrome. The combination of bulbar dysfunction, gait issues, and this specific sleep pathology is pathognomonic.\n\n*   Anti-Hu (Option A): Associated with paraneoplastic sensory neuronopathy and encephalomyelitis (often with small cell lung cancer). While it can cause brainstem symptoms, the specific sleep architecture described is not characteristic.\n*   Anti-Ma2 (Option B): Associated with diencephalic, midbrain, and brainstem encephalitis (often with testicular tumors). It typically causes severe hypersomnia (narcolepsy-like) and vertical gaze palsy, rather than the complex parasomnias and insomnia described here.\n*   Anti-LGI1 (Option C): Associated with limbic encephalitis. The hallmark is faciobrachial dystonic seizures and hyponatremia.\n*   Anti-DPPX (Option E): Associated with CNS hyperexcitability (myoclonus, tremor) and severe prodromal gastrointestinal symptoms (diarrhea, weight loss).\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-009", "question": "A 2-year-old boy presents with eczema, thrombocytopenia, and recurrent pyogenic infections. He has small platelets on peripheral smear. Genetic testing reveals a mutation in the WAS gene. Which of the following malignancies is this patient at the highest risk of developing?", "options": ["Non-Hodgkin Lymphoma", "Acute Myeloid Leukemia", "Neuroblastoma", "Hepatoblastoma", "Osteosarcoma"], "answer": "A", "answer_index": 0, "explanation": "Wiskott-Aldrich Syndrome (WAS) is an X-linked disorder characterized by the triad of eczema, immunodeficiency, and thrombocytopenia with small platelets. Due to defective T-cell function and immune surveillance, these patients have a significantly elevated risk of lymphoreticular malignancies, particularly Non-Hodgkin Lymphoma (often EBV-positive).", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-012", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "A", "model_outputs": "Based on the clinical presentation of eczema, thrombocytopenia with small platelets, recurrent infections, and a mutation in the *WAS* gene, the diagnosis is Wiskott-Aldrich Syndrome (WAS).\n\nPatients with Wiskott-Aldrich Syndrome have a significant immunodeficiency affecting both T and B cells. This immunodeficiency predisposes them to severe, recurrent infections and a high risk of developing autoimmune disorders and malignancies.\n\nThe most common malignancies developed by patients with Wiskott-Aldrich Syndrome are lymphoreticular malignancies, specifically Non-Hodgkin Lymphoma (often Epstein-Barr virus-positive). The risk of developing lymphoma is much higher than that of leukemia or solid tumors like neuroblastoma, hepatoblastoma, or osteosarcoma.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p05", "question_id": "ABMS20260101_gemini-3-pro-preview_p05-010", "question": "A 2-year-old boy presents with failure to thrive and chronic steatorrhea. Examination reveals absent deep tendon reflexes and ataxia. A peripheral blood smear demonstrates numerous acanthocytes. A lipid panel shows extremely low levels of cholesterol and triglycerides, and absent LDL. Which of the following is the primary pathophysiology?", "options": ["Defect in the LDL receptor", "Mutation in the ABCA1 gene", "Microsomal triglyceride transfer protein (MTP) deficiency", "Lipoprotein lipase deficiency", "Apolipoprotein C-II deficiency"], "answer": "C", "answer_index": 2, "explanation": "This is Abetalipoproteinemia (Bassen-Kornzweig syndrome). It is caused by a mutation in the MTP gene, which is required for the assembly and secretion of apoB-containing lipoproteins (Chylomicrons, VLDL, LDL). The absence of these lipoproteins leads to fat malabsorption (steatorrhea), vitamin E deficiency (spinocerebellar degeneration, absent DTRs), and lipid membrane defects (acanthocytosis).", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "topics_mapped", "source_label_raw": "Pediatrics", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed125.jsonl", "pred": "C", "model_outputs": "Based on the clinical presentation and laboratory findings, the diagnosis is Abetalipoproteinemia (Bassen-Kornzweig syndrome).\n\n1.  Clinical Picture: The patient presents with fat malabsorption (steatorrhea, failure to thrive) because the intestine cannot form chylomicrons to transport dietary fats. The neurologic symptoms (ataxia, absent deep tendon reflexes) are due to severe deficiency of fat-soluble vitamins, particularly Vitamin E.\n2.  Laboratory Findings: Acanthocytes (spurred red blood cells) are a hallmark finding due to altered membrane lipid composition. The lipid panel showing extremely low cholesterol/triglycerides and absent LDL (beta-lipoprotein) confirms the absence of ApoB-containing lipoproteins.\n3.  Pathophysiology: This condition is caused by an autosomal recessive mutation in the *MTTP* gene, which leads to a deficiency of microsomal triglyceride transfer protein (MTP). MTP is essential for loading lipids onto Apolipoprotein B-48 (in the intestine) and Apolipoprotein B-100 (in the liver). Without MTP, chylomicrons, VLDL, and LDL cannot be assembled or secreted into the bloodstream.\n\n*   Option A causes Familial Hypercholesterolemia (high LDL).\n*   Option B causes Tangier disease (deficiency of HDL).\n*   Option D and Option E cause Type I Hyperlipoproteinemia (high triglycerides/chylomicrons, pancreatitis).\n\nThe answer is (C)"}]